News | July 25, 2012

Technology Allows More Atlanta Patients to Self-Manage Their Heart Disease

Data on how Emmi Solutions’ technology improves patient flow, care and reimbursement to be showcased at AHA’s 2012 Leadership Summit

July 25, 2012 — Grady Memorial Hospital has standardized and improved patient education and reduced by 75 percent the amount of time staff spend educating new patients about warfarin by implementing Emmi Solutions’ interactive multimedia program in its Coumadin clinic. This has allowed Grady, the largest hospital in Georgia and the public hospital for Atlanta, to add 138 patient appointment slots per month to better meet the needs of a growing heart disease population. This study was selected as a poster display at the 20thAnnual Health Forum and the American Hospital Association Leadership Summit to be held July 19 to July 21 in San Francisco.

Grady previously had to limit the number of new patient visits to its Coumadin clinic per day due to the length of time — nearly 90 minutes — required to help each new patient understand their condition and self-management responsibilities. This could delay the date of the first visit for new patients.

Despite Grady’s heavily underserved, older patient population – which includes many computer novices – 100 percent of patients participate in the interactive multimedia program during their clinic visit. The program educates them about their condition and treatment, and engages them to actively self-manage their care.

Grady Health System is one of the largest public health systems in the United States. Grady consists of the 953-bed Grady Memorial Hospital, six neighborhood health centers, Crestview Health & Rehabilitation Center, and Children's Healthcare of Atlanta at Hughes Spalding, which is operated as a Children's affiliate.

Emmi’s proprietary interactive communication methodology – which incorporates graphics, text and spoken words – delivers actionable health information to patients at key moments across the continuum of care. It has been demonstrated to help healthcare providers reduce costs, increase revenue and improve outcomes by engaging and empowering patients. The platform allows providers to track the delivery and consumption of information to measure the clinical and financial impact of patient engagement and meet regulatory guidelines. The web-based platform requires no installation or maintenance and can be used in stand-alone mode or fully integrated into existing systems.

For more information: www.gradyhealth.org


Related Content

News | Pharmaceuticals

February 16, 2024 — AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company focusing on ...

Home February 16, 2024
Home
News | Pharmaceuticals

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti ...

Home January 25, 2024
Home
News | Pharmaceuticals

November 21, 2023 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home November 21, 2023
Home
Feature | Pharmaceuticals | By Christine Book

In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor ...

Home October 25, 2023
Home
Videos | Pharmaceuticals

In this third and final segment in DAIC’s “One on One” series with Dr. Christine Seidman, learn what’s on the horizon at ...

Home September 26, 2023
Home
Videos | Pharmaceuticals

In Part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based ...

Home September 11, 2023
Home
Videos | Pharmaceuticals

A 3-part video series with Christine E. Seidman, MD, FACC, FAHA In the first of this 3-part “One on One” series, Dr ...

Home August 28, 2023
Home
News | Pharmaceuticals

August 1, 2023 —LEXEO Therapeutics, a clinical-stage gene therapy company advancing adeno-associated virus (AAV)-based ...

Home August 01, 2023
Home
News | Pharmaceuticals

July 10, 2023 — Novartis announced that the US Food and Drug Administration (FDA) has approved a label update for Leqvio ...

Home July 10, 2023
Home
Subscribe Now